Patients With Lung Cancer Have High Susceptibility of COVID-19: A Retrospective Study in Wuhan, China

Cai, Hongbing

Patients With Lung Cancer Have High Susceptibility of COVID-19: A Retrospective Study in Wuhan, China

Posted on 2020-09-18 - 12:07

Patients with lung cancer are presumed to be at high risk from COVID-19 infection due to underlying malignancy. A total of 31 COVID-19 patients with pre-diagnosed lung cancer and 186 age and sex matched COVID-19 patients without cancer in 6 hospitals in Wuhan, China were identified in our study. There was a significantly higher level of IL-6 in lung cancer group showed by multifactorial analysis. The restricted mean survival time in 10, 20, and 53 days in COVID-19 patients with lung cancer were ealier than non-cancer COVID-19 patients in the same observation time (all P values < 0.05). Our results indicated that pre-diagnosed lung cancer was associated with higher morbidity and mortality in COVID-19 patients.

CITE THIS COLLECTION

DataCite

3 Biotech

3D Printing in Medicine

3D Research

3D-Printed Materials and Systems

4OR

AAPG Bulletin

AAPS Open

AAPS PharmSciTech

Abhandlungen aus dem Mathematischen Seminar der Universität Hamburg

ABI Technik (German)

Academic Medicine

Academic Pediatrics

Academic Psychiatry

Academic Questions

Academy of Management Discoveries

Academy of Management Journal

Academy of Management Learning and Education

Academy of Management Perspectives

Academy of Management Proceedings

Academy of Management Review

Dai, Meng-Yuan; Chen, Zhen; Leng, Yan; Wu, Meng; Liu, Yu; Zhou, Fuxiang; et al. (2020). Patients With Lung Cancer Have High Susceptibility of COVID-19: A Retrospective Study in Wuhan, China. SAGE Journals. Collection. https://doi.org/10.25384/SAGE.c.5126063.v1

https://doi.org/10.25384/SAGE.c.5126063.v1

or

Select your citation style and then place your mouse over the citation text to select it.